argenx reports third quarter 2019 financial results and provides business update

by NASDAQ Market News October 24, 2019

NASDAQ Market News
Click here to email author

Novartis receives approval for Cosentyx® label update in Europe to include dosing flexibility in ankylosing spondylitis

FDA Approves Myriad’s myChoice® CDx Test to Help Identify Women Eligible for Treatment with Zejula® in Late-line Ovarian Cancer

Ads